Investment Stage

Focus Areas

About Investor

Mike Kramer serves as Venture Partner at Vensana Capital, focusing on investments in medical devices, BioTech, drug delivery, diagnostics, and digital health across pre-seed, seed, Series A, and Series B stages with investment ranges between $10.0M and $40.0M. His professional background includes over 20 years of experience in operations, finance, and accounting, having previously served as an Operating Partner at CRG LP and as CFO or COO at private and public medical device companies including Endologix, TriVascular (IPO, acquired), and ATS Medical (IPO, acquired). Kramer brings extensive experience in medical devices and leadership roles within medical and clinical affairs to his role in Santa Rosa, California.